Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBLIVAC FIX Phleum Pratense Dose-Finding Study in Grass Pollen Allergy
NCT01682070Phase 2Completed
- Sponsor
- HAL Allergy Group
- Start
- Sep 2012
- Primary completion
- May 2013
- Modality
- Allergy Immunotherapy
- Countries
- 2
01
Overview
A Phase 2 trial of phleum pratense extract in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by HAL Allergy Group. Started Sep 2012; status: completed.
02
Drugs
phleum pratense extract
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01682070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01682070.